iiinova — where your digital self keeps evolving

Reposted by Nathaniel Reisinger

Nephrology Journal Club @nephjc.bsky.social · 22/06/2026

Is it time for a new leader in membranous nephropathy, or is it just a game of thrones 👑? This week we're discussing OBI vs TAC in the MAJESTRY trial from #ERA26 🏰🐑 #NephSky We welcome back from retirement @jamiekwillows.bsky.social with the summary ✍️ www.nephjc.com/news/2026/06/22-majestyobi

nephjc.com

Heir to the Throne? Obinutuzumab in the membranous nephropathy MAJESTY trial — NephJC

This week, NephJC will discuss whether obinutuzumab is ready to outperform tacrolimus in primary membranous nephropathy

01210

Reposted by Nathaniel Reisinger

ASNKidney @asnkidney.bsky.social · 04/11/2025

Early Programs kick off tomorrow at 7 a.m. CST as #KidneyWk begins in Houston! Get ready for a day of immersive, expert-led learning and discussion focused on key topics like Generative AI, transplant care, diabetes management, genetics, and more. A full day of learning awaits.

021

Reposted by Nathaniel Reisinger

American Journal of Kidney Diseases @ajkd.bsky.social · 16/07/2025

Perspective by Abhilash Koratala and Amir Kazory: Point-of-Care Ultrasound in Nephrology: Enthusiasm Alone Won’t Suffice; Training Is Key bit.ly/3FStYDW @nephropocus.bsky.social #POCUS

bit.ly

Point-of-Care Ultrasound in Nephrology: Enthusiasm Alone Won’t Suffice; Training Is Key

173

Reposted by Nathaniel Reisinger

NephroPOCUS @nephropocus.bsky.social · 11/06/2025

Advancing #Nephrology Education with #POCUS: Insights from the #KidneyWk 2024 @asnkidney.bsky.social Precourse. #Nephpearls #FOAMed 🔗 sciencedirect.com/science/arti... Glad to have co-authored this with @nephrothaniel.bsky.social

111

Reposted by Nathaniel Reisinger

POCUS Journal @pocusjournal.bsky.social · 15/04/2025

⚡️ The April issue of POCUS Journal, Vol 10 Issue 1, is out now! We invite you to visit our website (pocusjournal.com) to read articles of interest! 📷 pocusjournal.com/current-issue/ #POCUSJournal #POCUS #FOAMed #FOAMus #MedEd #MedTwitter #echofirst #echo #ultrasound

056

Nathaniel Reisinger @nephrothaniel.bsky.social · 10/04/2025

So grateful to the co-chairs @nephropocus.bsky.social & Amy Mosman for inviting me to the #pocus in nephrology early program @nkf-professionals.bsky.social #SCM25! Always a pleasure to serve with these distinguished thought leaders in the ultrasound-enhanced physical examination space!

052

Nathaniel Reisinger @nephrothaniel.bsky.social · 20/03/2025

Nephrology fellow @michaelturk6.bsky.social of @dukekidney.bsky.social lecturing on #pocus of kidney and bladder 8th annual #pocus immersion course at SW nephrology conference @nkf-professionals.bsky.social AZ

010

Reposted by Nathaniel Reisinger

Derek Lowe @dereklowe.bsky.social · 14/03/2025

3477

Reposted by Nathaniel Reisinger

Nathaniel Reisinger @nephrothaniel.bsky.social · 22/01/2025

Still time left to join our 2-day #pocus program @ SW Nephrology conference in Phoenix 3/20-3/21 @NKFArizona! swnephrologyconference.org $125 discount for trainees! Guaranteed surfeit of hemodynamic assessment! Featuring: @argaiz.bsky.social @asakhuja.bsky.social @michaelturk6.bsky.social

074

Reposted by Nathaniel Reisinger

Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 08/02/2025

Indications for mineralocorticoid receptor antagonists (MRAs) in the management of cardio-kidney risk from @theisn.org @kdigo.org @renalphysicians.bsky.social @aspcardio.bsky.social #Nephpearls #Cardiorenal #ISNWCN 🇮🇳 #WCN25 🇮🇳 👉🏼 www.theisn.org/initiatives/...

284

Reposted by Nathaniel Reisinger

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 07/02/2025

Next up is the HIT session Rajiv Agarwal on the baseline characteristics of the CONFIDENCE trial Simultaneous Finerenone + Empagliflozin in DKD #ISNWCN #NephSky

141

Nathaniel Reisinger @nephrothaniel.bsky.social · 22/01/2025

074